Folate and neurological function: Epidemiological perspective

Folate in Health and Disease, Second Edition

Volumn , Issue , 2009, Pages 325-353

  Morris, Martha Savaria ^a   Jacques, Paul F ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865113946     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (139)

1. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians; 75:307-20.
2. Young SN, Ghadirian AM. Folic acid and psychopathology. ProgNeuropsychopharmacol Biol Psychiatry 1989; 13:841-63.
3. Muntjewerff JW, Blom HJ. Aberrant folate status in schizophrenic patients: What is the evidence? Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:1133-39.
4. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277:813-17.
5. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-98.
6. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study. Am J Clin Nutr 2000; 71:993-98.
7. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006; 580:2994-3005.
8. Seshadri S. Elevated plasma homocysteine levels: Risk factor or risk marker for the development of dementia and Alzheimer’s disease? J Alzheimers Dis 2006; 9:393-98.
9. Durga J, van Boxtel MP, Schouten EG, Bots ML, Kok FJ, Verhoef P. Folate and the methylenetetrahydrofolate reductase 677C→T mutation correlate with cognitive performance. Neurobiol Aging 2006; 27:334-43.
10. Morris, MS, Jacques PF, Rosenberg IH, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73:927-33.
11. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A 3rd. High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005; 82:627-35.
12. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:1103-12.
13. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994; 48:137-52.
14. Reynolds EH, Carney MW, Toone BK. Methylation and mood. Lancet 1984; 2:196-98.
15. Shu L, Lee NP. SAMe targets consumers via the web. West J Med 2000; 173:229-30.
16. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992; 86:386-90.
17. Leblhuber F, Walli J, Widner B, Artner-Dworzak E, Fuchs D, Vrecko K. Homocysteine and B vitamins in dementia. Am J Clin Nutr 2001; 73:127-28.
18. Joosten E, Lesaffre E, Riezler R, Ghekiere V, Dereymaeker L, Pelemans W, Dejaeger E. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer’s disease? J Gerontol A Biol Sci Med Sci 1997; 52:M76-79.
19. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-57.
20. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49:31-62.
21. Lindeboom J, Weinstein H. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer’s disease, and vascular cognitive impairment. Eur J Pharmacol2004; 490:83-86.
22. Strachan MW, Price JF, Frier BM. Diabetes, cognitive impairment, and dementia. BMJ 2008; 336:6.
23. Wijekoon EP, Brosnan ME, Brosnan JT. Homocysteine metabolism in diabetes. Biochem Soc Trans 2007; 35:1175-79.
24. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006; 5:949-60.
25. Morris MS, Jacques PF, Rosenberg I, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 85:193-200.
26. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256:183-94.
27. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397-405.
28. Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW Jr, Rubin EH, Morris JC. Absence of cognitive impairment or decline in preclinical Alzheimer’s disease. Neurology 2001; 56:361-67.
29. Andrews-Hanna JR, Snyder AZ, Vincent JL, Lustig C, Head D, Raichle ME, Buckner RL. Disruption of large-scale brain systems in advanced aging. Neuron 2007; 56:924-35.
30. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.
31. Palmer K, Wang HX, Backman L, Winblad B, Fratiglioni L. Differential evolution of cognitive impairment in nondemented older persons: Results from the Kungsholmen Project. Am J Psychiatry 2002; 159:436-42.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington, DC: American Psychiatric Press Inc., 1994.
33. Riggs KM, Spiro A 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 1996; 63:306-14.
34. Huff FJ, Corkin S. Recent advances in the neuropsychology of Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8:643-48.
35. Hinman JD, Abraham CR. What’s behind the decline? The role of white matter in brain aging. Neurochem Res 2007; 32:2023-31.
36. de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, et al.MRI and CSF studies in the early diagnosis of Alzheimer’s disease. J Intern Med 2004; 256:205-23.
37. Bird CM, Burgess N. The hippocampus and memory: Insights from spatial processing. Nat Rev Neurosci 2008; 9:182-94.
38. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Multiple cognitive deficits during the transition to Alzheimer’s disease. J Intern Med 2004; 256:195-204.
39. Wadley VG, Crowe M, Marsiske M, Cook SE, Unverzagt FW, Rosenberg AL, Rexroth D. Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study. J Am Geriatr Soc 2007; 55:1192-98.
40. Salthouse TA. The processing-speed theory of adult age differences in cognition. Psychol Rev 1996; 103:403-28.
41. Proust-Lima C, Amieva H, Dartigues JF, Jacqmin-Gadda H. Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies. Am J Epidemiol 2007; 165:344-50.
42. Morrens M, Hulstijn W, Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull 2007; 33:1038-53.
43. Strachan RW, Henderson JG. Dementia and folate deficiency. Q J Med 1967; 36:189-204.
44. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983; 249:2917-21.
45. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ. Nutritional status and cognitive functioning in a normally aging sample: A 6-y reassessment. Am J Clin Nutr 1997; 65:20-29.
46. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology 2001; 56:1188-94.
47. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346:476-83.
48. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004; 62:1972-76.
49. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005; 82:636-43.
50. Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias JL, Aggarwal NT. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer’s disease. J Alzheimers Dis 2006; 9:435-43.
51. Kim JM, Stewart R, Kim SW, Yang SJ, Shin HY, Shin IS, Yoon JS. Changes in folate, vitamin B12, and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008; 79:864-68.
52. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr2007; 85:511-17.
53. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64:86-92.
54. Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN, Green R, Miller JW. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005; 82:1346-52.
55. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13:235-39.
56. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland, PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-55.
57. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80:114-22.
58. Monastero R, Palmer K, Qiu C, Winblad B, Fratiglioni L. Heterogeneity in risk factors for cognitive impairment, no dementia: Population-based longitudinal study from the Kungsholmen Project. Am J Geriatr Psychiatry 2007; 15:60-69.
59. Campbell AK, Jagust WJ, Mungas DM, Miller JW, Green R, Haan MN, Allen LH. Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine, is associated with dementia in elderly Latinos. J Nutr Health Aging 2005; 9:39-43.
60. Morris MC, Evans DA, Bienias JL, Tangney CC, Hebert LE, Scherr PA, Schneider JA. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol 2005; 62:641-45.
61. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002; 132:2792-98.
62. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PW, Rosenberg IH, Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001; 131:3277-80.
63. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002; 33:2351-56.
64. Harris Interactive. MetLife Foundation Alzheimer’s Survey: What America Thinks. Metlife Foundation; 2006 [cited March 20, 2008]. Available from: http://www.metlife.com/WPSAssets/20538296421147208330V1FAlzheimersSurvey.pdf.
65. U.S. Department of Health and Human Services. National Health and Nutrition Examination Survey 1999-2000 [cited March 21, 2008]. National Center for Health Statistics. Available from: http://www.cdc.gov/nchs/data/nhanes/frequency/cfq_doc.pdf.
66. Constitution of the World Health Organization. Am J Public Health Nations Health1946 Nov; 36(11):1315-23.
67. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003; 53:214-21.
68. Lindeman RD, Romero LJ, Koehler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ. Serum vitamin B12, C and folate concentrations in the New Mexico elder health survey: Correlations with cognitive and affective functions. J Am Coll Nutr 2000; 19:68-76.
69. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75:908-13.
70. Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, Haan MN. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2003; 78:441-47.
71. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003; 77:668-73.
72. Wright CB, Lee HS, Paik MC, Stabler SP, Allen RH, Sacco RL. Total homocysteine and cognition in a tri-ethnic cohort: The Northern Manhattan Study. Neurology 2004; 63:254-60.
73. Feng L, Ng TP, Chuah L, Niti M, Kua EH. Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: Findings from the Singapore Longitudinal Ageing Study. Am J Clin Nutr 2006; 84:1506-12.
74. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 1999; 150:283-89.
75. Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM. Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology 2002; 59:1375-80.
76. Budge MM, de Jager C, Hogervorst E, Smith AD. Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc2002; 50:2014-18.
77. Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Garry PJ. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 2003; 13:595-600.
78. Kang JH, Irizarry MC, Grodstein F. Prospective study of plasma folate, vitamin B12, and cognitive function and decline. Epidemiology 2006; 17:650-57.
79. Nurk E, Refsum H, Tell GS, Engedal K, Vollset SE, Ueland PM, Nygaard HA, Smith AD. Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine Study. Ann Neurol 2005; 58:847-57.
80. Elias MF, Sullivan LM, D’Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham offspring study: Age is important. Am J Epidemiol 2005; 162:644-53.
81. Hector M, Burton JR. What are the psychiatric manifestations of vitamin B12 deficiency?J Am Geriatr Soc 1988; 36:1105-12.
82. Garcia A, Haron Y, Pulman K, Hua L, Freedman M. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: A prospective follow-up study. J Gerontol A Biol Sci Med Sci 2004; 59:1323-27.
83. Schafer JH, Glass TA, Bolla KI., Mintz M, Jedlicka AE, Schwartz BS. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc2005; 53:381-88.
84. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, Verhoef P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised, double blind, controlled trial. Lancet 2007; 369:208-16.
85. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354:2764-72.
86. Lewerin C, Nilsson-Ehle H, Matousek M, Lindstedt G, Steen B. Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: A randomised trial. Eur J Clin Nutr 2003; 57:1426-36.
87. Pathansali R, Mangoni AA, Creagh-Brown B, Lan ZC, Ngow GL, Yuan XF, Ouldred EL, Sherwood RA, Swift CG, Jackson SH. Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects. Arch Gerontol Geriatr 2006; 43:127-37.
88. Fioravanti M, Frerrario E, Massaia M, Cappa G, Rivolta G, Grossi E, Buckley AE. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr 1997; 26:1-3.
89. Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. JNutr 2002; 132:1345-56.
90. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press, 1998.
91. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 1996; 126:1266S-72S.
92. Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc 2002; 50:1789-95.
93. Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60:2-11.
94. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr 2002; 132:2799-803.
95. Carney MW, Sheffield BF. Serum folic acid and B12 in 272 psychiatric in-patients. Psychol Med 1978; 8:139-44.
96. Bottiglieri T, Crellin R, Reynolds EH. Folate and neuropsychiatry. In: Bailey LB, ed., Folate in Health and Disease, New York: Marcel Dekker, 1995:435-62.
97. Papakostas GI, Petersen T, Lebowitz BD, Mischoulon D, Ryan JL, Nierenberg AA, Bottiglieri T, Alpert JE, Rosenbaum JF, Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int JNeuropsychopharmacol 2005; 8:523-28.
98. Lerner V, Kanevsky M, Dwolatzky T, Rouach T, Kamin R, Miodownik C. Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clin Nutr 2006; 25:60-67.
99. Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989; 80:78-82.
100. Coppen A, Chaudhry S, Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord 1986; 10:9-13.
101. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336:392-95.
102. Spector R, Lorenzo AV. Folate transport in the central nervous system. Am J Physiol1975; 229:777-82.
103. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: The Rotterdam Study. Am J Psychiatry 2002; 159:2099-101.
104. Nierenberg AA. Current perspectives on the diagnosis and treatment of major depressive disorder. Am JManag Care 2001; 7:S353-66.
105. Aragones E, Pinol JL, Labad A. The overdiagnosis of depression in non-depressed patients in primary care. Fam Pract 2006; 23:363-68.
106. Boland RJ, Diaz S, Lamdan RM, Ramchandani D, McCartney JR. Overdiagnosis of depression in the general hospital. Gen Hosp Psychiatry 1996; 18:28-35.
107. Perry SW, Cella DF. Overdiagnosis of depression in the medically ill. Am J Psychiatry1987; 144:125-26.
108. Eaton WW, Neufeld K, Chen LS, Cai G. A comparison of self-report and clinical diagnostic interviews for depression: Diagnostic interview schedule and schedules for clinical assessment in neuropsychiatry in the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry 2000; 57:217-22.
109. Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH. A 40-year perspective on the prevalence of depression: The Stirling County Study. Arch Gen Psychiatry 2000; 57:209-15.
110. Murakami K, Mizoue T, Sasaki S, Ohta M, Sato M, Matsushita Y, Mishima N. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition 2008; 24:140-47.
111. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP. Vitamin B(12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women’s Health and Aging Study. Am J Psychiatry 2000; 157:715-21.
112. Miyake Y, Sasaki S, Tanaka K, Yokoyama T, Ohya Y, Fukushima W, Saito K, Ohfuji S, Kiyohara C, Hirota Y. Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: The Osaka Maternal and Child Health Study. J Affect Disord 2006; 96:133-38.
113. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US population. Psychother Psychosom 2003; 72:80-87.
114. Tolmunen T, Hintikka J, Ruusunen A, Voutilainen S, Tanskanen A, Valkonen VP, Viinamaki H, Kaplan GA, Salonen JT. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom 2004; 73:334-39.
115. Tolmunen T, Voutilainen S, Hintikka J, Rissanen T, Tanskanen A, Viinamaki H, Kaplan GA, Salonen JT. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. JNutr 2003; 133:3233-36.
116. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60:618-26.
117. Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D. Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: The Zutphen Elderly Study. Eur J Clin Nutr 2008; 62:939-45.
118. Ramos MI, Allen LH, Haan MN, Green R, Miller JW. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am J Clin Nutr 2004; 80:1024-28.
119. Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, Christensen H, Jorm AF. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med 2005; 35:529-38.
120. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association, 1980.
121. Tison P. [Structured interview guide for evaluating depression in elderly patients, adapted from DSM IV and the GDS, HDRS and MADRS scales]. Encephale 2000; 26:33-43.
122. Adams KB. Depressive symptoms, depletion, or developmental change? Withdrawal, apathy, and lack of vigor in the Geriatric Depression Scale. Gerontologist 2001; 41:768-77.
123. Copeland JR, Prince M, Wilson KC, Dewey ME, Payne J, Gurland B. The Geriatric Mental State Examination in the 21st century. Int J Geriatr Psychiatry 2002; 17:729-32.
124. Devanand DP, Adorno E, Cheng J, Burt T, Pelton GH, Roose SP, Sackeim HA. Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients. J Affect Disord 2004; 78:259-67.
125. Scogin F, Rohen N, Bailey E. Geriatric Depression Scale. In: Maruish ME, ed., Handbook of Psychological Assessment in Primary Care Settings, Mahwah, NJ: Lawrence Erlbaum Associates, Inc, 2000:491-508.
126. Galloway M, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol 2003; 56:924-26.
127. VanItallie TB. Subsyndromal depression in the elderly: Underdiagnosed and undertreated. Metabolism 2005; 54:39-44.
128. Blazer DG. Depression in late life: Review and commentary. J Gerontol A Biol Sci Med Sci 2003; 58:249-65.
129. Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, vitamin B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997; 154:426-28.
130. Gilbody S, Bower P, Torgerson D, Richards D. Cluster randomized trials produced similar results to individually randomized trials in a meta-analysis of enhanced care for depression. J Clin Epidemiol 2008; 61:160-68.
131. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial. J Affect Disord 2000; 60:121-30.
132. Passeri M, Cucinotta D, Abate G, Senin U, Ventura A, Stramba Badiale M, Diana R, La Greca P, Le Grazie C. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study. Aging (Milano)1993; 5:63-71.
133. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: Its use in a community sample. Am J Psychiatry 1983; 140:41-46.
134. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, Seeman TE. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005; 118:161-67.
135. Clark MS, Guthrie JR, Dennerstein L. Hyperhomocysteinemia is associated with lower performance on memory tasks in post-menopausal women. Dement Geriatr Cogn Disord 2005; 20:57-62.
136. Elias MF, Robbins MA, Budge MM, Elias PK, Brennan SL, Johnston C, Nagy Z, Bates CJ. Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: The Maine-Syracuse study. Psychosom Med 2006; 68:547-54.
137. de Lau LM, Refsum H, Smith AD, Johnston C, Breteler MM. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr 2007; 86:728-34.
138. Stott DJ, Macintosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, Tait RC, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005; 82:1320-26.
139. Tettamanti M, Garri MT, Nobili A, Riva E, Lucca U. Low folate and the risk of cognitive and functional deficits in the very old: The Monzino 80-plus study. J Am Coll Nutr 2006; 25:502-08.